ACADEMIC PHARMACEUTICALS
Soestolol, a short-acting ester prodrug of sotalol for acute arrhythmia treatment
- Sector
- Biotech
- Headquarters
- Lake Bluff, IL
- Total capital
- $615K
- Federal grants
- $615K
- 4 awards · 2017–2019
- Rank in peer group#384 of 392
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 9
- 10 pending · first 2013
- Rank in peer group#14 of 392
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · Soestolol: A potentially short acting Type III anti-arrhythmic$153K
- Federal grantHealth and Human S · Phase I · Soestolol: A potentially short acting Type III anti-arrhythmic$153K
- Federal grantHealth and Human S · Phase I · Developing a Parenteral Formulation of Metolazone$158K
- Federal grantHealth and Human S · Phase I · A Safer Cardiac, Abuse Deterrent Formulation of Methadone$150K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 392 peers
Line = medianBiotech · Molecule
- Federal grantsBelow median
- Granted patents#14 · top 4%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 9 granted of 19- PendingDown Titration Loading Of Sotalol IntravenouslyUSPTOApplication 18939387
- PendingShort Acting Esters Of IvabradineUSPTOApplication 18963877
- GrantedUltra Short Acting Anti-arrhythmic AgentsUSPTOUS 12,258,309
Show all 19 patent records
- Down Titration Loading Of Sotalol IntravenouslyMay 7, 2026 · Application 18939387Pending
- Short Acting Esters Of IvabradineJun 5, 2025 · Application 18963877Pending
- Ultra Short Acting Anti-arrhythmic AgentsMar 25, 2025 · US 12,258,309Granted
- Method Of Initiating Or Escalating Dofetilide Dose And Formulations ThereforApr 16, 2024 · US 11,957,648Granted
- Ultra Short Acting Anti-arrhythmic AgentsAug 22, 2023 · US 11,731,938Granted
- Metolazone Emulsion FormulationJul 19, 2022 · US 11,389,451Granted
- Method Of Initiating Or Escalating Dofetilide Dose And Formulations ThereforJun 21, 2022 · US 11,364,213Granted
- Ultra Short Acting Anti-arrhythmic AgentsMar 29, 2022 · US 11,286,235Granted
- Ultra Short Acting Anti-arrhythmic AgentsOct 6, 2020 · US 10,793,519Granted
- Parenteral Solutions Containing MetolazoneAug 30, 2016 · US 9,427,398Granted
- Parenteral Dextrose Formulation Of ClopidogrelAug 20, 2013 · US 8,513,278Granted
- Method of initiating or escalating dofetilide dose in hospital maximizing patient safety while shortening the time period required for electrocardiographic monitoringApplication 62689442Pending
- Ultra Short Acting Anti-arrhythmic AgentsApplication 62665584Pending
- Metolazone Emulsion FormulationApplication 62557210Pending
- Parenteral Formulation Of ClopidogrelApplication PCTUS2010059194Pending
- Synthesis And Separation Of Optically Active Isomers Of Erythromycin And Their Biological ActionsApplication PCTUS2001044423Pending
- Ultra Short Acting Anti-arrhythmic AgentsApplication 63199436Pending
- Short Acting Esters Of IvabradineApplication 63604486Pending
- Metolazone Emulsion FormulationApplication PCTUS2018050340Pending
Related companies, and why
- PAXVAX, INC.Similar federal contract value in Biotech · null in contracts
- RAPHAEL PHARMACEUTICALS LLCSimilar federal contract value in Biotech · null in contracts
- BE BiopharmaSimilar federal contract value in Biotech · null in contracts
- Medley GenomicsSimilar federal contract value in Biotech · null in contracts
- Sequegenics LLCSimilar federal contract value in Biotech · null in contracts
- GENEDIT INCSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .